hiv

Merck to participate in new research efforts to eradicate HIV

Published on Mon, 07/11/2011 - 13:37
By FNNO Staff in General Interest, MRK, aids, business, finance, grant, hiv, market, merck, news, price, research, share, stock, university, News Update
aids, business, finance, grant, hiv, market, merck, news, price, research, share, stock, university

Merck (NYSE:MRK) announced that company researchers will participate in two new collaborative efforts led by the prominent academic institutions of the University of North Carolina Chapel Hill and the University of California San

By FNNO Staff
fnnonline@gmail.com

Healthcare Sector Update: March 23, 2011

Published on Wed, 03/23/2011 - 15:19
By Stephanie Shyu in General Interest, gild, XOMA, clinical trial, disease, gild, gilead, healthcare, hiv, infection, medical, patients, retroviral, science, sector, shares, stock, treatment, viral, virus, xoma, Health & Pharma Report
clinical trial, disease, gild, gilead, healthcare, hiv, infection, medical, patients, retroviral, science, sector, shares, stock, treatment, viral, virus, xoma

Health care shares are lower in mid-session trading while Xoma (XOMA) tumbles after disappointing results from a clinical trial. The company is down nearly 30% in early trading, after it said late Tuesday its Phase 2b trial of XOM

By Stephanie Shyu
sshyu@fnno.com

Sangamo BioSciences Firms Nearly 3% After HIV/AIDS Treatment Data Presented at Conference

Published on Thu, 03/03/2011 - 11:09
By Stephanie Shyu in General Interest, SGMO, aids, business, drugs, higher, hiv, income, investment, market, news, pharmaceuticals, sangamo biosciences, shares, stocks, trade, News Update
aids, business, drugs, higher, hiv, income, investment, market, news, pharmaceuticals, sangamo biosciences, shares, stocks, trade

Sangamo BioSciences (SGMO) is up after it says data from its programs to develop ZFN-based therapeutic approaches for the treatment of HIV/AIDS were discussed in four oral presentations at the 18th Conference on Retroviruses and O

By Stephanie Shyu
sshyu@fnno.com

Gilead Sciences Acquires Calistoga Pharmaceuticals for $375

Published on Tue, 02/22/2011 - 14:34
By FNNO Staff in General Interest, gild, acquire, acquisition, calistoga, cancer, cash, company, drugs, flu, gild, gilead, health, hiv, medicine, merger, pharma, research, sciences, shares, stock, tamiflu, vaccine, Mergers & Acquisitions
acquire, acquisition, calistoga, cancer, cash, company, drugs, flu, gild, gilead, health, hiv, medicine, merger, pharma, research, sciences, shares, stock, tamiflu, vaccine

Gilead Sciences (GILD) today announced that it has acquired Calistoga Pharmaceuticals, a privately held company, for $375 million. GILD stated that with the acquisition, it hopes to expand its research capabilities into cancer dru

By FNNO Staff
fnnonline@gmail.com

Abbott Labs' HIV Drug Kaletra Denied Patent Protection in India; Shares Rise 0.3%

Published on Tue, 01/04/2011 - 14:05
By Stephanie Shyu in General Interest, abt, abbott, abt, drug, generic, hiv, india, kaletra, laboratories, labs, market, reject, shares, stock
abbott, abt, drug, generic, hiv, india, kaletra, laboratories, labs, market, reject, shares, stock

Shares of Abbott Laboratories (ABT) are higher even as copyright protection for the company's HIV drug Kaletra was rejected in India, which will allow other generic drug companies to manufacture copies, Bloomberg reports. The pro

By Stephanie Shyu
sshyu@fnno.com

Latest News from FNNO

Earnings Look Back: Comcast Is Up 3.1% S...

When Comcast (NASDAQ:CMCSK) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 6th, 2013 Liberty Global (NASDAQ:LBTYA) reported earnings and analyst ...

Earnings Look Back: Kelly Services Is Up...

When Kelly Services (NASDAQ:KELYA) reported earnings a week ago on May 8th, 2013, analy ...

Liberty Media Earnings Review: 10 Days a...

When Liberty Media (NASDAQ:LINTA) reported earnings a week ago on May 8th, 2013, analys ...

Central Garden and Pet Earnings Hindsigh...

A week ago on May 8th, 2013 Central Garden and Pet (NASDAQ:CENTA) reported earnings and ...

Comcast Earnings Review: 17 Days after A...

When Comcast (NASDAQ:CMCSA) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 7th, 2013 Discovery Communications (NASDAQ:DISCA) reported earnings a ...

Jazz Pharmaceuticals Earnings In Retrosp...

11 days ago, on May 7th, 2013, Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its earnings ...

Most Popular Video News

  •
    01:10 PM MIDWEEK MARKET WRAP UP:New Report Expected to Shakeup Libor

    From FNNO.com, this is the Financial News Network. I’m Cleo
    Stiller-Farrell and this is your Midweek Market Wrap Up. The British
    Bankers’ Association, which has the supervisory role of setting the
    influential Libor rates, announced that it would be willing to give up
    its...

    +
  • 11:04 AM What's in the News for September 26, 2012

    The Wall Street Journal reports that home prices showed their best year-to-date gains since 2005, up 5.9% through July, signaling the housing market's steady march toward recovery. Also from the Wall Street Journal, IBM (IBM) will increase its efforts to sell so-called cloud computing services...

    +
  • 11:04 AM Yahoo Makes Ken Goldman New CFO

    CEO Marissa Mayer is bringing in some more new blood to Yahoo!, tapping Ken Goldman as the company's new Chief Financial Officer. Goldman's appointment will take effect on October 22nd.

    Goldman served as CFO at his most recent employer, Fortinet, having worked at Siebel Systems, Sybase,...

    +
More